Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomized controlled trials
- PMID: 34555319
- DOI: 10.1016/j.ajog.2021.09.015
Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a network meta-analysis of randomized controlled trials
Abstract
Objective: To assess the efficacy of mechanical strategies to avoid the recurrence of intrauterine adhesions, to evaluate the impact on subsequent fertility after hysteroscopic adhesiolysis and to rank the available antiadhesive options.
Data sources: MEDLINE, Scopus, ClinicalTrials.gov, CINAHL, Scielo, EMBASE, PROSPERO, Cochrane Library, conference proceedings, and international controlled trials registries were searched without temporal, geographic, and language restrictions.
Study eligibility criteria: Randomized trials that analyzed the recurrence, reproductive outcomes, or both in women undergoing hysteroscopic adhesiolysis followed by mechanical prevention of intrauterine adhesions were included. The exclusion criteria included the following: quasi-randomized trials and trials without randomization and studies including patients undergoing hysteroscopic surgery that was different from adhesiolysis.
Study appraisal and synthesis methods: The Preferred Reporting Items for Systematic reviews and Meta-Analyses extension statement for network meta-analyses guidelines were followed. We performed a network meta-analysis based on the random effects model for mixed multiple treatment comparisons to rank the antiadhesive strategies by surface under the cumulative ranking curve area. Quality assessment was performed using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions. The primary outcome was the recurrent presence of intrauterine adhesions.
Results: Eleven studies with data for 1596 women were identified as applicable. A copper intrauterine device together with an intrauterine balloon (surface under the cumulative ranking curve area=46.4%) or with cross-linked hyaluronic acid gel (surface under the cumulative ranking curve area=21.3%) seemed effective in preventing adhesions recurrence. Regarding the fecundity, hyaluronic acid gel demonstrated the highest pregnancy rates (surface under the cumulative ranking curve area=79.8%). The greatest degrees of change in the mean adhesions scores were found with the use of hyaluronic acid gel plus an intrauterine device (surface under the cumulative ranking curve area=38.9%). For postsurgical adhesion severity, hyaluronic acid gel plus intrauterine device (surface under the cumulative ranking curve area=49.9%) followed by intrauterine device alone (surface under the cumulative ranking curve area=30.8%) was ranked the highest. Dried amnion graft (surface under the cumulative ranking curve area=53.8%) and uterine balloon (surface under the cumulative ranking curve area=45%) showed the greatest menstrual pattern improvement.
Conclusion: Cross-linked hyaluronic acid gel, with or without insertion of a copper intrauterine device, seems to be the most effective approach. However, the lack of a clear best therapy suggests the need for further studies to draw firm conclusions.
Keywords: Asherman syndrome; adhesion recurrence; hysteroscopy; intrauterine adhesions; reproductive outcomes.
Copyright © 2021 Elsevier Inc. All rights reserved.
Comment in
-
Postsurgical barrier strategies to avoid the recurrence of intrauterine adhesion formation after hysteroscopic adhesiolysis: a comment.Am J Obstet Gynecol. 2022 Jun;226(6):869-870. doi: 10.1016/j.ajog.2022.02.016. Epub 2022 Feb 17. Am J Obstet Gynecol. 2022. PMID: 35183500 No abstract available.
-
Postsurgical antiadhesive barriers to reduce the risk of recurrence after hysteroscopic adhesiolysis: a reply.Am J Obstet Gynecol. 2022 Jun;226(6):870-871. doi: 10.1016/j.ajog.2022.02.015. Epub 2022 Feb 18. Am J Obstet Gynecol. 2022. PMID: 35183503 No abstract available.
Similar articles
-
Meta-analysis on the use of hyaluronic acid gel to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.Taiwan J Obstet Gynecol. 2019 Nov;58(6):731-736. doi: 10.1016/j.tjog.2019.09.002. Taiwan J Obstet Gynecol. 2019. PMID: 31759520 Review.
-
Meta-analysis of the use of amniotic membrane to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.Int J Gynaecol Obstet. 2018 Nov;143(2):145-149. doi: 10.1002/ijgo.12635. Epub 2018 Aug 29. Int J Gynaecol Obstet. 2018. PMID: 30073656 Review.
-
Auto-Cross-Linked Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis: A Randomized Controlled Trial.J Minim Invasive Gynecol. 2021 Feb;28(2):307-313. doi: 10.1016/j.jmig.2020.06.030. Epub 2020 Jul 15. J Minim Invasive Gynecol. 2021. PMID: 32681996 Clinical Trial.
-
Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study.Hum Reprod. 2003 Sep;18(9):1918-21. doi: 10.1093/humrep/deg368. Hum Reprod. 2003. PMID: 12923149 Clinical Trial.
-
Effectiveness of Hyaluronic Acid Gel and Intrauterine Devices in Prevention of Intrauterine Adhesions after Hysteroscopic Adhesiolysis in Infertile Women.J Minim Invasive Gynecol. 2022 Feb;29(2):284-290. doi: 10.1016/j.jmig.2021.08.010. Epub 2021 Aug 22. J Minim Invasive Gynecol. 2022. PMID: 34433103
Cited by
-
Comparison of clinical outcomes and second-look hysteroscopy of the complete and incomplete septate uterus after hysteroscopic septoplasty.Arch Gynecol Obstet. 2024 Jan;309(1):227-233. doi: 10.1007/s00404-023-07243-x. Epub 2023 Oct 10. Arch Gynecol Obstet. 2024. PMID: 37816880
-
Uterine cervical stenosis: from classification to advances in management. Overcoming the obstacles to access the uterine cavity.Arch Gynecol Obstet. 2024 Mar;309(3):755-764. doi: 10.1007/s00404-023-07126-1. Epub 2023 Jul 10. Arch Gynecol Obstet. 2024. PMID: 37428263 Free PMC article. Review.
-
Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?Arch Gynecol Obstet. 2024 Jan;309(1):205-210. doi: 10.1007/s00404-023-07238-8. Epub 2023 Oct 2. Arch Gynecol Obstet. 2024. PMID: 37782418
-
Emergent Hysteroscopic Removal of Retained Products of Conception Following Laparoscopic Temporary Uterine Artery Ligation.Gynecol Minim Invasive Ther. 2024 Sep 7;13(4):260-264. doi: 10.4103/gmit.gmit_11_24. eCollection 2024 Oct-Dec. Gynecol Minim Invasive Ther. 2024. PMID: 39660238 Free PMC article.
-
Visualized hysteroscopic artificial intelligence fertility assessment system for endometrial injury: an image-deep-learning study.Ann Med. 2025 Dec;57(1):2478473. doi: 10.1080/07853890.2025.2478473. Epub 2025 Mar 17. Ann Med. 2025. PMID: 40098308 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical